Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients

Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients

Summary: Background: The main objective of the present study was to analyze both clinical characteristics and evolution during hospitalization of a cohort of patients admitted for COVID-19 pneumonia who were not vaccinated, or with a complete or incomplete vaccination schedule. Methods: This COVID-...

Full description

Bibliographic Details
Main Authors:	Jose Rafael Teran-Tinedo, Jesus Gonzalez-Rubio, Alberto Najera, Andrea Castany-Faro, Maria de las Nieves Contreras, Isabel Maria Garcia, Lourdes Lopez-Mellado, Miguel Lorente-Gonzalez, Patricia Perez-Garvin, Galaxia Sacristan-Crespo, Miguel Suarez-Ortiz, Juan D Navarro-Lopez, Lydia Jimenez-Diaz, Pedro Landete
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	EClinicalMedicine
Subjects:	COVID-19 Vaccines Vaccinated patients Pfizer BNT162b2 AstraZeneca
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537022001833

Similar Items

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
by: Waleed H. Mahallawi, et al.
Published: (2021-12-01)

Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study
by: Muhammad Nauman Zahid
Published: (2021-11-01)

Exploration of Correlations between COVID-19 Vaccination Choice and Public Mental Health Using Google Trend Search
by: Shao-Cheng Wang, et al.
Published: (2022-12-01)

Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
by: Krzysztof Lukaszuk, et al.
Published: (2022-03-01)

Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis
by: Abdulaziz Alhossan, et al.
Published: (2022-12-01)

EVENTOS ADVERSOS À 3ª DOSE DAS VACINAS ASTRAZENECA E PFIZER EM UMA COORTE DE TRABALHADORES DA SAÚDE
by: Maria da Penha Gomes Gouvea, et al.
Published: (2023-10-01)

An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
by: Suhaila A. Al-Sheboul, et al.
Published: (2022-12-01)

Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients
by: Abdel-Ellah Al-Shudifat, et al.
Published: (2023-08-01)

Global interest in vaccines during the COVID‐19 pandemic: Evidence from Google Trends
by: Aida Khakimova, et al.
Published: (2022-04-01)

Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
by: Heba M. Attash, et al.
Published: (2022-01-01)

A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
by: Marian S. Boshra, et al.
Published: (2022-02-01)

Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
by: Donato Gemmati, et al.
Published: (2022-11-01)

Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines
by: Osama Abu-Hammad, et al.
Published: (2021-06-01)

Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile
by: Abdulaziz Ibrahim Alzarea, et al.
Published: (2022-06-01)

Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers
by: Sylwia Kałucka, et al.
Published: (2022-03-01)

Surveillance of COVID-19 vaccines: A comprehensive analysis of the first immunization drive in Ecuador
by: Andrea Orellana-Manzano, et al.
Published: (2024-03-01)

Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians
by: Md. Anwarul Azim Majumder, et al.
Published: (2022-06-01)

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2022-02-01)

Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
by: Uraporn Phumisantiphong, et al.
Published: (2023-04-01)

Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?
by: Patrícia Diogo, et al.
Published: (2022-04-01)

COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series
by: Shitiz Sriwastava, et al.
Published: (2022-03-01)

Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
by: Lama T AlMutairi, et al.
Published: (2022-06-01)

Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis
by: Hind A. ElSawi, et al.
Published: (2022-05-01)

Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
by: Thoybah Yousif Ibrahim Gabralla, et al.
Published: (2022-12-01)

Crisis Communication during COVID-19: English, French, Portuguese, and Spanish Discourse of AstraZeneca Vaccine and Omicron Variant on Social Media
by: Daniel Catalan-Matamoros, et al.
Published: (2023-06-01)

COVID-19 Vaccination Trends and Side Effects among Egyptian Hemodialysis Patients: A Multicenter Survey Study
by: Mohammed Kamal Nassar, et al.
Published: (2022-10-01)

ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report
by: Welder Zamoner, et al.
Published: (2022-10-01)

Local myofascitis of the deltoid muscle after administration of the AstraZeneca (AZD1222) COVID-19 vaccine: two cases, infectious and inflammatory
by: Jong Pil Yoon, MD, et al.
Published: (2022-08-01)

Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection
by: Zeinab Aryanian, et al.
Published: (2022-04-01)

Effect of different COVID-19 vaccines on some biomarkers in diabetics
by: Munther Kamil Oudha, et al.
Published: (2023-04-01)

Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study
by: Adisu Asefa, et al.
Published: (2023-11-01)

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran
by: Shahin Soltani, et al.
Published: (2023-07-01)

Systemic and cutaneous side effects of COVID-19 vaccines in Iraq, A cross-sectional study
by: Rzan Abdulhasan Al-Battat, et al.
Published: (2024-05-01)

Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: A cross-sectional study
by: Mohamad Klib, et al.
Published: (2024-01-01)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01)

Adverse effects following COVID-19 vaccination in Iran
by: Ebrahim Babaee, et al.
Published: (2022-05-01)

An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
by: Nguyen Van Vinh Chau, et al.
Published: (2021-11-01)

“First episode psychosis following the anti-COVID vaccination: a case reports”
by: Eloi Giné-Servén, et al.
Published: (2021-11-01)

Concomitant myocarditis and painless thyroiditis after AstraZeneca coronavirus disease 2019 vaccination: a case report
by: Apichai Marsukjai, et al.
Published: (2022-05-01)

Fulminant hepatitis following COVID‐19 vaccination: A case report
by: Mohammad Barary, et al.
Published: (2022-07-01)